Trial Profile

An extension study assessing AT-007 in Galactosemia

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 26 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Govorestat (Primary)
Indications Galactosaemia
Focus Adverse reactions; Registrational

Most Recent Events

12 Nov 2020 According to a Applied Therapeutics Media release, the company plans to submit an NDA no later than Q3 2021.
15 Jun 2020 According to an Applied Therapeutics Media release, NDA submission will include the data from this study.
15 Jun 2020 Results published in the Applied Therapeutics Media Release

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com